Business Wire

O-RAN Alliance Conducts First Global Plugfest to Foster Adoption of Open and Interoperable 5G Radio Access Networks

19.12.2019 13:57:00 EET | Business Wire | Press release

Share

The O-RAN Alliance successfully conducted its first worldwide plugfest and proof of concept to demonstrate the functionality as well as the multi-vendor interoperability of network equipment that complies with the recently published O1, A1, and Open Fronthaul interface specifications.

“O-RAN’s first global plugfest showcases the power of the community to document and develop truly open interface specifications with the potential to accelerate new 5G advanced services that will be multi-operator, multi-vendor, and create opportunities for the entire ecosystem,” said Andre Fuetsch, Chairman of the O-RAN Alliance and Chief Technology Officer of AT&T. “These live demonstrations represent yet another step toward the realization of O-RAN compliant 5G RAN solutions that should soon become part of the product offerings of both mainstream and niche vendors.”

ASIA

Hosted by China Mobile, the plugfest Asian Session was held in the China Mobile International Information Port, an Open Test and Integration Center, with physical attendance well over 200 attendees from over 70 companies, plus on-line attendance of over 70 participants. Representatives from global operators including British Telecom, China Telecom, China Unicom, NTT DOCOMO, Orange, Reliance Jio, Telecom Italia Mobile and an operator from North America have actively participated in this event. The plugfest tested and integrated multi-vendor solutions that comply with the O-RAN Open Fronthaul interface and exercised decoupling different hardware technologies from the RAN software:

  1. Cloud-based small cell running on virtualization technology was demonstrated by CertusNet, Lenovo, ChengDu NTS and Inventec. It features a VM-based O-CU and containerized O-DU cohosted on the same x86 processor plus accelerator platform.
  2. Multi-vendor interoperability with 5G commercial products was demonstrated by NTT DOCOMO with Fujitsu and NEC.
  3. A low power configuration of cloud base station running on Yocto OS and container technology was demonstrated by Altran, ArrayComm, WindRiver, Baicells and CIG. It features the open architecture baseband signal processing based on ARM processor plus accelerator computing platform.
  4. Soft base station with O-RAN compliant open fronthaul interface, but without virtualization, was demonstrated by Radisys, Foxconn (Taiwan), QCT and Intel. It leverages open source software including the O-RAN Open Source Community’s OFH Lib, and BBDev based Accelerator Abstraction Layer SDK API.
  5. The interworking of the O-RAN open fronthaul interface was demonstrated on technology provided by FHK (Shenzen) and Viavi, which performs comprehensive tests based on the test specification by O-RAN with O-RU and UE emulator in a multiple-UE test environment.

The plugfest held in the NTT DOCOMO R&D Center presented multi-vendor interoperability between CU/O-DU and O-RU using the O-RAN Open Fronthaul interface and multi-vendor interoperability between eNB and gNB using the O-RAN X2 interface. The functionality has been successfully demonstrated by NTT DOCOMO, Fujitsu, NEC, and Nokia. NTT DOCOMO has already started 5G pre-commercial service with the presented products. An Open Test and Integration Center is planned to be established in Japan.

NORTH AMERICA

The plugfest and proof-of-concept conducted within an Open Test and Integration Center candidate in North America, 5G COSMOS, which consists of vendor and university labs in the NYC metro area, was hosted by AT&T and focused primarily on the validation of the O1 and A1 interfaces:

  1. Physical Network Function (PNF) Plug and Play, a 3GPP-aligned O1 use case that provides a means for service providers to collaborate with equipment vendors to have PNFs discovered by Service Management Orchestration (SMO) via a PNF registration handler, was demonstrated by Nokia, CommScope and Ericsson. Remote SMO functions were also demonstrated with connections to labs in France and Germany.
  2. Bulk Performance Management Data Collection was demonstrated by Ericsson and Nokia.
  3. O1 interface functionality for Configuration, Performance, and Fault Management of multi-vendor equipment via a vendor-agnostic SMO was demonstrated by Altiostar, CommScope, and Samsung.
  4. A1 interface functionality to optimize PCI/RSI for a large-scale RAN simulator using a closed loop automation framework was demonstrated by IBM, Tech Mahindra, Wipro and highstreet technologies.
  5. Convergence of the Open Fronthaul Management Plane specification with O1 interface was demonstrated by Samsung.

“The O-RAN Alliance has been continuously expanding its influence in the industry since its inception. It is really amazing to see such a symbolic milestone achieved just 10 months since its release of the first specification in MWC Barcelona this year,” said Zhengmao Li, EVP of China Mobile. “The successful holding of the plugfest event globally with deep contribution from over 30 partners represents a consolidated step towards a full disaggregated O-RAN compliant 5G network.”

Dr. Hiroshi Nakamura, EVP and CTO, NTT DOCOMO commented, "We believe wide adoption of O-RAN compliant products will enable more agile, flexible and cost-effective network construction, and welcome the testing and integration efforts of O-RAN standards that are being carried out across the globe. NTT DOCOMO will continue to lead O-RAN Alliance activities and expand its 5G network, and will accelerate the co-creation of 5G services and markets with vertical industry partners."

O-RAN Industry Briefing at MWC 2020

For a comprehensive update on O-RAN activities, including significant developments in Europe, the O-RAN community will come together for the O-RAN Industry Briefing event at MWC Barcelona 2020. Representatives from O-RAN operator and vendor member organizations will discuss and share views on the important steps towards realizing O-RAN compliant commercial solutions. O-RAN Alliance is looking forward to meeting you on Feb 25, 2020, 9:30-10:30 am at the Deutsche Telekom Booth, Hall 3, Booth 3M31.

About O-RAN Alliance

O-RAN Alliance is a world-wide community of more than 130 mobile operators, vendors, and research & academic institutions operating in the Radio Access Network (RAN) industry. As the RAN is an essential part of any mobile network, O-RAN Alliance’s mission is to re-shape the industry towards more intelligent, open, virtualized and fully interoperable mobile networks. The new O-RAN standards will enable a more competitive and vibrant RAN supplier ecosystem with faster innovation to improve user experience. O-RAN-compliant mobile networks will at the same time improve the efficiency of RAN deployments as well as operations by the mobile operators. To achieve this, O-RAN Alliance publishes new RAN specifications, releases open software for the RAN, and supports its members in integration and testing of their implementations.

For more information please visit www.o-ran.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

O-RAN Alliance PR Contact

Zbynek Dalecky
pr@o-ran.org
O-RAN Alliance e.V.
Buschkauler Weg 27
53347 Alfter/Germany

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T)13.7.2026 15:32:00 EEST | Press release

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that the U.S. Food & Drug Administration (FDA) granted Rare Pediatric Disease (RPD) Designation for its proprietary lead small molecule drug candidate NB4168 for the treatment of Ataxia Telangiectasia (A-T). NB4168 is an oral small molecule therapy engineered to deliver substantially greater nicotinamide riboside (NR) exposure than conventional NR while maintaining a differentiated pharmacokinetic and safety profile. In addition, the European Medicines Agency (EMA) has granted Orphan Medicinal Product Designation (OMPD) to NB4168 for the treatment of A-T, providing regulatory recognition in the European Union and further supporting the Company's plans to advance the program globally. The FDA granted RPD Designation based on its determination that A-T is a serious and life-threatening disease that primarily affects individ

Esri Introduces ArcGIS Velocity for ArcGIS Enterprise to Power Real-Time GIS Operations13.7.2026 15:00:00 EEST | Press release

Esri, the global leader in location intelligence, has released for general availability ArcGIS Velocity for ArcGIS Enterprise for self-hosted deployments on Windows and Linux. This enables organizations to leverage Velocity from secure on-premises and private cloud environments. Available as software as a service (SaaS) for ArcGIS Online and now for self-hosted environments in ArcGIS Enterprise, Esri’s next-generation geospatial capability delivers real-time analytics on streaming, Internet of Things (IoT), sensor, and asset data. It helps organizations track and visualize public events, supply chains, and infrastructure to identify and respond to potential threats. ArcGIS Velocity for ArcGIS Enterprise expands cloud-native support to enterprise customers across industries in government and business that rely on firewall protection and internal security compliance. ArcGIS Velocity connects to more than 20 ready-to-use feeds for real-time data providers, including Dataminr, Samsara, Fli

HistoSonics Receives CE Mark, Unlocking Access Across Europe and Accelerating Global Commercialization of the Edison® Histotripsy Platform13.7.2026 15:00:00 EEST | Press release

HistoSonics, today announced that the company has received CE Mark approval in Europe for its Edison® System, enabling commercialization of the company’s non-invasive histotripsy technology in Europe and other markets that recognize the CE Mark. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260713505048/en/ HistoSonics Edison® Histotripsy System The Edison System is a novel, non-invasive, image guided platform that is intended for the destruction of liver tumors, including the partial or complete destruction of unresectable liver tumors. It uses the mechanical properties of focused ultrasound, called histotripsy, to liquefy and destroy unwanted tissue and tumors in a single procedure without the need for invasive procedures or radiation, and with potentially fewer side effects than traditional therapies. CE Mark approval follows an increasing number of regulatory clearances and was supported by a growing body of clinical ev

SLB OneSubsea Awarded EPC Contract for Eni’s Baleine Phase 3 Project Offshore Côte d'Ivoire13.7.2026 15:00:00 EEST | Press release

Global energy technology company SLB (NYSE: SLB) announced today that its OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260712734539/en/ SLB OneSubsea™ joint venture has been awarded a major multi-well engineering, procurement, and construction (EPC) contract by Eni for Phase 3 of the deepwater Baleine project offshore Côte d’Ivoire. Under the contract, SLB OneSubsea will deliver complete subsea production systems (SPS) for 13 wells, reinforcing its role as a core technology and execution partner on one of the most strategically significant offshore developments currently underway in the region. The EPC scope includes subsea trees, umbilical, manifolds, multiphase flowmeters and control systems, along with installation, commissionin

Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer13.7.2026 13:00:00 EEST | Press release

Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that it has entered into a securities purchase agreement for a private placement of approximately $85 million in upfront gross proceeds, before the deduction of private placement expenses, and up to an additional $255 million upon the full exercise of purchase warrants. The financing was led by Commodore Capital, with participation from RA Capital Management, TCGX, Invus, and Ligand Pharmaceuticals. The net proceeds of this financing are expected to support Agenus’ strategic prioritization of botensilimab and balstilimab (BOT+BAL) for the neoadjuvant treatment of microsatellite-stable (MSS) colon cancer, including advancement of ROBBIN1, the Company’s planned registrational Phase 3 neoadjuvant trial in microsatellite-stable (MSS) colon cancer. High-risk Stage II and Stage III MSS colon cancer affect an estimated 38,000 patients annually in the US and more than 200,000 patients worldwide,2 representing a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye